Stay updated with breaking news from Exscientia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exscientia (NASDAQ:EXAI – Get Rating) had its target price trimmed by Morgan Stanley from $15.00 to $14.00 in a report released on Monday, Benzinga reports. The firm currently has an equal weight rating on the stock. Exscientia Stock Performance NASDAQ EXAI opened at $5.31 on Monday. Exscientia has a twelve month low of $4.09 and […]
Exscientia (NASDAQ:EXAI – Get Rating) and X4 Pharmaceuticals (NASDAQ:XFOR – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk. Analyst Recommendations This is a breakdown of current recommendations and […]
Exscientia plc (NASDAQ:EXAI – Get Rating) shares shot up 3.2% during trading on Wednesday . The stock traded as high as $5.20 and last traded at $5.20. 8,853 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 289,077 shares. The stock had previously closed at $5.04. Exscientia Stock […]
Exscientia plc (NASDAQ:EXAI – Get Rating)’s stock price dropped 5.8% on Thursday . The company traded as low as $5.25 and last traded at $5.32. Approximately 100,223 shares traded hands during trading, a decline of 66% from the average daily volume of 295,813 shares. The stock had previously closed at $5.65. Exscientia Price Performance The […]
Exscientia plc Recent developments in the Company’s pipeline, collaborations, and operations as well as financial results for the fourth quarter and full year 2022 are summarised below.... | March 23, 2023